# OnCusp Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oncusp-therapeutics

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.oncusptx.com
- Total disclosed funding: $125M
- Latest round: Series A (Jan 4, 2024)
- Investors on record: 13

## About

Established in 2021 and based in New York, US, OnCusp Therapeutics operates as a biopharmaceutical company dedicated to providing oncology medicines. It has a sub-branch office in Shanghai. The co-Founder, Chairman and CEO of the company, Bin Yuan graduated from Columbia University and has worked in CStone Pharmaceuticals and Merck & Co. The CCO of the company, Tian Fu graduated from University of Connecticut and has worked in CStone Pharmaceuticals and Deloitte Touche Tohmatsu. In January 2024, OnCusp Therapeutics raised USD 100 million in series A funding.

The company has three product pipelines CUSP06, CUSP03, and CUSP02. CUSP06 is an ADC (Antibody–drug conjugate) targeting CDH6 (cadherin-6, is a type II classical cadherin from the cadherin superfamily), which is suitable for solid tumours. The CUSP03 and CUSP02 are suitable for haematologic and solid tumours. The CUPS06 is in Pre-Clinical period, and CUSP03 and CUSP02 are still in the development stage.

The company will advance the clinical proof-of-concept of the company’s CDH6-targeting antibody drug conjugate CUSP06.

## Funding rounds

- Series A, Jan 4, 2024, $100M — OrbiMed Advisors, Sofinnova Investments, Novo Holdings, F-Prime Capital, Marshall Wace, Blackbird Ventures, BioTrack Capital, Catalio Capital Management, Forge Life Science Partners, CJNV BioVenture
- Seed, Jun 29, 2021, $25M — Oriza Holdings, BioTrack Capital, AIHC Capital, Sequoia China

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Seed
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Seed, Series A
- AIHC Capital — Seed
- Sequoia China — Seed
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A
- Novo Holdings — Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A
- Marshall Wace (https://capitalatlas.ai/funds/marshall-wace) — Series A
- Blackbird Ventures (https://capitalatlas.ai/funds/blackbird-ventures) — Series A
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series A
- Forge Life Science Partners (https://capitalatlas.ai/funds/forge-life-science-partners) — Series A
- CJNV BioVenture — Series A